AdipoGen Life Sciences

Artesunate

CHF 70.00
In stock
AG-CN2-0469-M100100 mgCHF 70.00
AG-CN2-0469-M500500 mgCHF 210.00
AG-CN2-0469-G0011 gCHF 370.00
More Information
Product Details
Synonyms Artesunic acid; Qinghaozhi
Product Type Chemical
Properties
Formula

C19H28O8

MW 384.4
CAS 88495-63-0
Source/Host Chemicals Semi-synthetic derivative of artemisinin originally isolated from Artemisia annua.
Purity Chemicals ≥98% (HPLC)
Appearance White solid.
Solubility Soluble in DMSO or ethanol. Sparingly soluble in aqueous buffers.
InChi Key FIHJKUPKCHIPAT-AHIGJZGOSA-N
Smiles [H][C@@]12CC[C@@H](C)[C@]3([H])CC[C@]4(C)OO[C@@]13[C@]([H])(O[C@@H](OC(=O)CCC(O)=O)[C@@H]2C)O4
Shipping and Handling
Shipping AMBIENT
Short Term Storage +4°C
Long Term Storage +4°C
Handling Advice Keep cool and dry.
Protect from light.
Protect from moisture and oxygen.
Use/Stability Stable for at least 1 year after receipt when stored at +4°C.
Documents
MSDS Download PDF
Product Specification Sheet
Datasheet Download PDF
Description
  • Semi-synthetic derivative of artemisinin.
  • Anti-malaria.
  • Anti-schistosomiasis.
  • Inhibitor of human cytomegalovirus (CMV).
  • Apoptosis inducer.
  • Anti-cancer.
  • Immunosuppressant. 
  • Inhibits production of tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), monocyte chemotactic protein-1 (MCP-1) and nitric oxide (NO).
  • Functional ARX inhibitor.
  • Enhancer of GABAA signalling.
  • Targets Gephyrin.
  • Inducer of glucose-6-phosphate dehydrogenase (G6PDH) activity (25fold), the rate limiting enzyme of the pentose phosphate pathway (PPP).
  • Sown to have anti-SARS-CoV-2 activity with an EC50 of 12.98 ± 5.30μM, and beeing potentially useful in the treatment of COVID-19.
Product References
  1. The antimalarial and toxic effect of artesunate on animal models: J. Tradit. Chin. Med. 2, 99 (1982)
  2. Prevention of red cell lysis in artesunate-treated rats: A role for glucose-6-phosphate dehydrogenase: T.M. Salman; Afr. J. Biotech. 8, 139 (2008)
  3. Efficacy of praziquantel and artemisinin derivatives for the treatment and prevention of human schistosomiasis: a systematic review and meta-analysis: R. Liu, et al.; Parasit. Vectors 4, 201 (2011)
  4. Evaluation of the immunosuppressive activity of artesunate in vitro and in vivo: T. Li, et al.; Int. Immunopharmacol. 16, 306 (2013)
  5. Inhibition of human cytomegalovirus replication by artemisinins: effects mediated through cell cycle modulation: S. Roy, et al.; Antimicrob. Agents Chemother. 59, 3870 (2015)
  6. Repurposing the anti-malarial drug artesunate as a novel therapeutic agent for metastatic renal cell carcinoma due to its attenuation of tumor growth, metastasis, and angiogenesis: D.E. Jeong, et al.; Oncotarget 6, 33046 (2015)
  7. Artemisinins target GABAA receptor signaling and impair α cell identity: J. Li, et al.; Cell 168, 86 (2017)
  8. Anti-SARS-CoV-2 Potential of Artemisinins In Vitro: R. Cao, et al.; ACS Infect. Dis. 6, 2524 (2020)
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.